XML 85 R73.htm IDEA: XBRL DOCUMENT
v3.23.2

Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Outstanding By Grant Year) (Details) - Stock Settled Stock Appreciation Rights SARS [Member] - $ / shares shares in Thousands | 12 Months Ended |
--- | --- | ---
Jun. 30, 2023 | Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |  |
Outstanding, Number Outstanding (in rights) | 155 | 393
Outstanding, Weighted Average Remaining Contractual Life in Years | 2 years 1 month 24 days |
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 165.77 | $ 158.12
Exercisable, Number Exercisable (in rights) | 122 |
Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 162.57 |
Year2021 [Member] |  |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |  |
Outstanding, Number Outstanding (in rights) | 78 |
Outstanding, Weighted Average Remaining Contractual Life in Years | 2 years 7 months 20 days |
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 177.79 |
Exercisable, Number Exercisable (in rights) | 45 |
Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 177.76 |
Year2020 [Member] |  |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |  |
Outstanding, Number Outstanding (in rights) | 76 |
Outstanding, Weighted Average Remaining Contractual Life in Years | 1 year 7 months 28 days |
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 153.71 |
Exercisable, Number Exercisable (in rights) | 76 |
Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 153.71 |
Year2019 [Member] |  |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |  |
Outstanding, Exercise Price (in dollars per share) | $ 154.48 |
Outstanding, Number Outstanding (in rights) | 1 |
Outstanding, Weighted Average Remaining Contractual Life in Years | 7 months 28 days |
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 154.48 |
Exercisable, Number Exercisable (in rights) | 1 |
Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 154.48 |
Minimum [Member] | Year2021 [Member] |  |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |  |
Outstanding, Exercise Price (in dollars per share) | 167.18 |
Minimum [Member] | Year2020 [Member] |  |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |  |
Outstanding, Exercise Price (in dollars per share) | 153.71 |
Maximum [Member] | Year2021 [Member] |  |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |  |
Outstanding, Exercise Price (in dollars per share) | 187.30 |
Maximum [Member] | Year2020 [Member] |  |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |  |
Outstanding, Exercise Price (in dollars per share) | $ 154.22 |

X
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercise Price + References No definition available. + Details
Name: | lanc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePrice
Namespace Prefix: | lanc_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of fully vested and exercisable stock-settled stock appreciation rights outstanding as of the balance sheet date that can be currently converted into shares of our common stock under the plan. + References No definition available. + Details
Name: | lanc_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockSettledStockAppreciationRightsExercisableAndVestedNumber
Namespace Prefix: | lanc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of stock-settled stock appreciation rights outstanding and currently exercisable under the stock plan. + References No definition available. + Details
Name: | lanc_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockSettledStockAppreciationRightsExercisableWeightedAverageExercisePrice
Namespace Prefix: | lanc_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average price at which grantees can exercise outstanding stock-settled stock appreciation rights. + References No definition available. + Details
Name: | lanc_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockSettledStockAppreciationRightsOutstandingWeightedAverageExercisePrice
Namespace Prefix: | lanc_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=lanc_Year2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=lanc_Year2020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardDateAxis=lanc_Year2019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |